RegSmart year summary 2022

Another year has passed. And what a year!

We have settled in just fine in our new offices at Eklundshovsvägen 5, strengthened our senior consultancy team and added new services to our portfolio.

Let us summarize the highlights.

A strengthened RegSmart team

We have welcomed experts in project management, regulatory drug development and medical device to our team.

New services – project management and clinical development plans

Project management is a critical factor for a successful project delivery. Therefore, it was a natural next step for us to expand our business with this offering early this year.

In September, we also added clinical development plans to our services through sub-contracting two experts within this area. The rationale for this is that small companies in drug and medical device development often need help to get an overall development plan and budget, with realistic time and cost aspects for the project’s development. 

With both project management and clinical development plans in our portfolio, we are able to support customers through development projects in a more efficient way.

We welcomed RegFile, our new sister company

During spring, we welcomed our new sister company, RegFile. RegFile´s offer complements RegSmart´s perfectly. RegSmart focus on the regulatory plan that will take the product to market, RegFile contributes with the final regulatory steps in a drug’s journey to marketing authorisation, and beyond. Together we cover the full regulatory scope. RegFile and RegSmart are both part of the Center of Translational Research Sweden group, CTR, together with Clinical Trials Consultants, Lablytica, Toxicology Knowledge Team Sweden and Metasafe.

Thank you, customers and partners!

Throughout the year, we have had the privilege to team up with you, our customers and partners. Together we have moved pharma and medical device development projects forward, with one mutual aim – to turn life science research and innovative ideas into safe products for patients, and fulfilling market needs.

Next year

During 2023, we have plans for working closer with partners in different constellations and ways, to be able to support you with our regulatory services in even better ways.
Keep an eye open, more information to come!

Now we want to wish you – our customers, partners and friends – a Merry Christmas and a Happy New Year. We look forward to continuing our journey with you in 2023.